TOP STORIES
respiratory
Asthma

Mepolizumab ‘super responders’ seen in severe eosinophilic asthma


Real world patients with severe eosinophilic asthma show the same good outcomes with mepolizumab as seen in clinical trials – with a particular group of ‘super responders’ with a T2 phenotype, an Australian study has shown. A registry based study...

Real world patients with severe eosinophilic asthma show the same good outcomes with mepolizumab as seen in clinical trials –...

Read more